Journal of Cutaneous Maedicine and Surgery 2014-01-01

Cytomegalovirus retinitis: a rare but preventable cause of blindness in dermatology patients.

Philip M Laws, Timothy P Kingston, Scott Walsh, Neil H Shear

Index: J. Cutan. Med. Surg. 18(4) , 287-90, (2014)

Full Text: HTML

Abstract

Dermatologists are using an increasing range of immunomodulatory therapies to treat an expanding number of skin diseases. Complications of therapy are broad and include infection. Cytomegalovirus (CMV) retinitis has not been reported in association with dermatologic disease.We report two cases of CMV retinitis associated with immunosuppression for eczema and pemphigus vulgaris. In both cases, patients were receiving corticosteroid and a second-line immunosuppressive agent (cyclosporine or mycophenolate mofetil). Disease presented in both patients with painless visual loss.Patients receiving immunosuppressive therapy should be monitored for blurred vision, floaters, or visual loss and referred for urgent assessment to ensure accurate diagnosis and prompt treatment of possible CMV retinitis.

Related Compounds

  • Cyclosporin A
  • Mycophenolic acid
  • prednisolone
  • Mycophenolate mofe...

Related Articles:

Proteomic analysis in serum of rat hind-limb allograft tolerance induced by immunosuppressive therapy with adipose-derived stem cells.

2014-12-01

[Plast. Reconstr. Surg. 134(6) , 1213-23, (2014)]

Differentiation between human ClC-2 and CFTR Cl- channels with pharmacological agents.

2014-09-01

[Am. J. Physiol. Cell Physiol. 307(5) , C479-92, (2014)]

The Ca²⁺-calmodulin-Ca²⁺/calmodulin-dependent protein kinase II signaling pathway is involved in oxidative stress-induced mitochondrial permeability transition and apoptosis in isolated rat hepatocytes.

2014-09-01

[Arch. Toxicol. 88(9) , 1695-709, (2014)]

Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication.

2014-01-01

[PLoS ONE 9(11) , e112413, (2014)]

Toxicity of copper on isolated liver mitochondria: impairment at complexes I, II, and IV leads to increased ROS production.

2014-09-01

[Cell Biochem. Biophys. 70(1) , 367-81, (2014)]

More Articles...